Related references
Note: Only part of the references are listed.Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis
Aaron E. Miller et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
ADVANCE Phase 3 Study of PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis: Patient Baseline Characteristics (P01.133)
P. Calabresi et al.
NEUROLOGY (2012)
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study
Bhupendra Khatri et al.
LANCET NEUROLOGY (2011)
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
N. De Stefano et al.
NEUROLOGY (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study
G. Tedeschi et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
Frederik Barkhof et al.
NATURE REVIEWS NEUROLOGY (2009)
Gray matter atrophy in multiple sclerosis: A longitudinal study
Elizabeth Fisher et al.
ANNALS OF NEUROLOGY (2008)
Brain volume decline in aging
Anthony F. Fotenos et al.
ARCHIVES OF NEUROLOGY (2008)
Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters
A. Minneboo et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
R. Zivadinov et al.
NEUROLOGY (2008)
Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis
Bas Jasperse et al.
ARCHIVES OF NEUROLOGY (2007)
Brain atrophy in multiple sclerosis: what we know and would like to know
J. H. Simon
MULTIPLE SCLEROSIS JOURNAL (2006)
Magnetic resonance imaging measures of brain atrophy in multiple sclerosis
VM Anderson et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2006)
The measurement and clinical relevance of brain atrophy in multiple sclerosis
RA Bermel et al.
LANCET NEUROLOGY (2006)
Regional brain changes in aging healthy adults: General trends, individual differences and modifiers
N Raz et al.
CEREBRAL CORTEX (2005)
Eight-year follow-up study of brain atrophy in patients with MS
E Fisher et al.
NEUROLOGY (2002)
Accurate, robust, and automated longitudinal and cross-sectional brain change analysis
SM Smith et al.
NEUROIMAGE (2002)
Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis
TP Leist et al.
ARCHIVES OF NEUROLOGY (2001)
Share Paper
